The Dubai Ruler and Deputy Prime Minister sent similar cables of condolences to the Prime Minister of Italy, Giorgia Meloni
The National Health Regulatory Authority (NHRA) today approved the emergency use of the oral Covid-19 antiviral, Paxlovid. The medication has been authorised for individuals 18 years old and above who suffer from mild to moderate symptoms and are at an increased risk of developing severe Covid-19 that may lead to mortality.
The decision follows the evaluation of data provided by the manufacturer Pfizer, carried out by the NHRA's Pharmaceutical Products Regulation Department (PPR).
The NHRA noted that The Ministry of Health has begun importing procedures in accordance with the relevant standards and requirements, with the medication expected to arrive in January.
ALSO READ:
Paxlovid consists of two, co-packaged antiviral medicine (PF-07321332 and Ritonavir) that are designed to stop the virus causing Covid-19 from multiplying in the body and therefore help those infected to overcome the viral infection.
The Dubai Ruler and Deputy Prime Minister sent similar cables of condolences to the Prime Minister of Italy, Giorgia Meloni
Abu Dhabi star underlines F2 dominance as battle for silver and bronze goes down to the wire
It is not immediately known how long the sailors were stranded in Yemen
Tight for second as Faysal Ayoubi and Charles Faulkner prevail on a countback
The Men in Green will kick off their campaign against The Netherlands on October 6 at the Rajiv Gandhi International Stadium in Hyderabad, India
Over 40 of Akasa's 450 pilots quit without serving their notice in recent weeks, causing 632 flight cancellations in August
He says migrants who risk drowning at sea 'must be rescued' because doing so was 'a duty of humanity'
In 16 ODIs this year, Babar scored 745 runs at an average of 49.66 and a strike rate of over 85